You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (78)

Journals (0)

1-10 of 78 results for afatinib

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings

Open access

Review article

First published 2020-9

Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings

R Donald Harvey, Val R Adams, Tyler Beardslee [...]

Journal of Oncology Pharmacy Practice

Select article: Synergistic Effect of HAD-B1 and Afatinib Against Gefitinib Resistance of Non-Small Cell Lung Cancer

Open access

Research article

First published 2022

Synergistic Effect of HAD-B1 and Afatinib Against Gefitinib Resistance of Non-Small Cell Lung Cancer

Si Yeon Song, Ji Hye Park, So-Jung Park [...]

Integrative Cancer Therapies

Select article: Overcoming T790M-driven Acquired Resistance to EGFR-TKIs in NSCLC with Afatinib: A Case Report

Retricted access

Research article

First published 2014-01

Overcoming T790M-driven Acquired Resistance to EGFR-TKIs in NSCLC with Afatinib: A Case Report

Paola Bordi, Marcello Tiseo, Beatrice Bortesi [...]

Tumori Journal

Select article: Afatinib with subsequent surgery in stage III NSCLC with EGFR mutation: Lessons learned from two clinical experiences

Retricted access

Case report

First published 2018-12

Afatinib with subsequent surgery in stage III NSCLC with EGFR mutation: Lessons learned from two clinical experiences

Francesca Mazzoni, Paolo Petreni, Marco Perna [...]

Tumori Journal

Select article: Long Progression-free Survival with Afatinib in a Patient with EGFR-unknown Lung Adenocarcinoma after Erlotinib Failure: A Case Report

Retricted access

Case report

First published 2015-3

Long Progression-free Survival with Afatinib in a Patient with EGFR-unknown Lung Adenocarcinoma after Erlotinib Failure: A Case Report

Maria Giuseppa Vitale, Sarah Scagliarini, Ferdinando Riccardi [...]

Tumori Journal

Select article: Optimizing afatinib dosage: enhancing treatment outcomes and minimizing toxicities in advanced EGFR-mutated non-small cell lung cancer patients in Vietnam

Open access

Research article

First published 2025

Optimizing afatinib dosage: enhancing treatment outcomes and minimizing toxicities in advanced EGFR-mutated non-small cell lung cancer patients in Vietnam

Cam Phuong Pham, Hung Kien Do, Anh Tu Do [...]

Therapeutic Advances in Medical Oncology

Select article: First-line afatinib for the treatment of EGFR mutation-positive non-small-cell lung cancer in the ‘real-world’ clinical setting

Open access

Review article

First published 2019

First-line afatinib for the treatment of EGFR mutation-positive non-small-cell lung cancer in the ‘real-world’ clinical setting

Keunchil Park, Darren Wan-Teck Lim, Isamu Okamoto [...]

Therapeutic Advances in Medical Oncology

Select article: Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study

Open access

Research article

First published 2022

Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study

Suey-Haur Lee, Yu-Ching Lin, Li-Chung Chiu [...]

Therapeutic Advances in Medical Oncology

Select article: The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation

Open access

Research article

First published 2020

The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation

Shang-Gin Wu, Chong-Jen Yu, James Chih-Hsin Yang [...]

Therapeutic Advances in Medical Oncology

Select article: Afatinib as first-line treatment in patients with EGFR -mutated non-small cell lung cancer in routine clinical practice

Open access

Research article

First published 2021

Afatinib as first-line treatment in patients with EGFR -mutated non-small cell lung cancer in routine clinical practice

Wolfgang M. Brückl, Martin Reck, Frank Griesinger [...]

Therapeutic Advances in Medical Oncology

1
2
3
•••
8
10 / page

Article type

Publication date

Subjects

Access